In 2004, 19-year-old Stanford University student Elizabeth Holmes dropped out of her chemical engineering program to incorporate a company she had founded the previous year; her plan was to revolutionize blood testing to make it faster, easier on patients, and far more accessible than existing methods allowed. The company was named Theranos. Skip ahead to 2018, and the company is all but done, with its promise to change the world left unfulfilled, its investors (who poured in roughly a billion dollars) burned, and its founder in a world of legal trouble. That’s all I should tell you about this case:…

This story continues at The Next Web